DARPA looks to harness SRI’s expertise to speed up tech transition — out of the lab into the real world — and scale DARPA-funded technologies for U.S. national and economic security outcomes.

The post SRI selected as DARPA’s Regional Commercial Accelerator appeared first on SRI.

SRI researchers study the cells of the long-living rodent to find new drug targets for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.

The post The naked mole rat may hold the key to new treatments for neurodegenerative diseases appeared first on SRI.

SRI scientists are developing a cell-based platform using an often-undervalued subset of helper T cells to deliver potent antitumor proteins for solid tumors, overcoming dose-related toxicities.

The post Engineered helper T cell could become a cancer killer appeared first on SRI.

As part of a nationwide longitudinal study of adolescent brain development, researchers use AI to analyze data to pinpoint obesity risk factors.

The post SRI identifies predictors of adolescent obesity appeared first on SRI.

SRI’s Senior Microbiologist Emeritus receives the prestigious Society for Industrial Microbiology and Biotechnology fellowship award for exceptional dedication.

The post Kristien Mortelmans: Decades of contributions to SRI and the fields of industrial, medical, and environmental microbiology appeared first on SRI.

Three experts offer actionable strategies to navigate social media, sleep, and helping prepare children for new routines.

The post Tips for back-to-school success appeared first on SRI.

The Chair of the SRI Board of Directors discusses SRI’s transformative role in the world.

The post David Motley: SRI’s leadership — and legacy of innovation appeared first on SRI.